1777 Stock Overview
Manufactures and sells active pharmaceutical ingredients (APIs) in Taiwan and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
SYN-TECH Chem. & Pharm. Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NT$97.10 |
| 52 Week High | NT$106.50 |
| 52 Week Low | NT$81.70 |
| Beta | 0.12 |
| 11 Month Change | 1.68% |
| 3 Month Change | 5.66% |
| 1 Year Change | 12.91% |
| 33 Year Change | 42.17% |
| 5 Year Change | 13.83% |
| Change since IPO | 381.33% |
Recent News & Updates
Recent updates
SYN-TECH Chem. & Pharm (GTSM:1777) Could Easily Take On More Debt
Mar 19
Here's What You Should Know About SYN-TECH Chem. & Pharm. Co., Ltd.'s (GTSM:1777) 4.6% Dividend Yield
Feb 26Declining Stock and Decent Financials: Is The Market Wrong About SYN-TECH Chem. & Pharm. Co., Ltd. (GTSM:1777)?
Feb 05
SYN-TECH Chem. & Pharm's (GTSM:1777) Shareholders Are Down 11% On Their Shares
Jan 10SYN-TECH Chem. & Pharm (GTSM:1777) Seems To Use Debt Rather Sparingly
Dec 19Here's What You Should Know About SYN-TECH Chem. & Pharm. Co., Ltd.'s (GTSM:1777) 4.6% Dividend Yield
Nov 28Shareholder Returns
| 1777 | TW Pharmaceuticals | TW Market | |
|---|---|---|---|
| 7D | 1.1% | 0.6% | -0.8% |
| 1Y | 12.9% | 9.2% | 29.0% |
Return vs Industry: 1777 exceeded the TW Pharmaceuticals industry which returned 9.2% over the past year.
Return vs Market: 1777 underperformed the TW Market which returned 29% over the past year.
Price Volatility
| 1777 volatility | |
|---|---|
| 1777 Average Weekly Movement | 2.2% |
| Pharmaceuticals Industry Average Movement | 3.8% |
| Market Average Movement | 4.5% |
| 10% most volatile stocks in TW Market | 8.0% |
| 10% least volatile stocks in TW Market | 2.1% |
Stable Share Price: 1777 has not had significant price volatility in the past 3 months compared to the TW market.
Volatility Over Time: 1777's weekly volatility (2%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1982 | 220 | n/a | www.syn-tech.com.tw |
SYN-TECH Chem. & Pharm. Co., Ltd. manufactures and sells active pharmaceutical ingredients (APIs) in Taiwan and internationally. The company offers products in various categories, such as anticoagulant, attention deficit hyperactivity disorder, skeletal muscle relaxant, antitussive, antipruritic, scabicide, anti-inflammatory, antipyretic, analgesic, muscle relaxant, anxiolytic, antiemetic, anticonvulsant, antiulcerative, dipeptidyl peptidase 4 inhibitor/antidiabetic, antihyertensive, a- blocker, vasodilator, bronchodilator, anxiolytic, tranquilizer, local anesthetic, decongestant, antispasmodic, neuroprotective, antimigraine, hvponatremia, antiglaucoma agent, pharmaceutic aid / lubricant, sedative, and analgesic.
SYN-TECH Chem. & Pharm. Co., Ltd. Fundamentals Summary
| 1777 fundamental statistics | |
|---|---|
| Market cap | NT$4.33b |
| Earnings (TTM) | NT$327.48m |
| Revenue (TTM) | NT$1.22b |
13.2x
P/E Ratio3.6x
P/S RatioIs 1777 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 1777 income statement (TTM) | |
|---|---|
| Revenue | NT$1.22b |
| Cost of Revenue | NT$762.85m |
| Gross Profit | NT$452.43m |
| Other Expenses | NT$124.95m |
| Earnings | NT$327.48m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 7.34 |
| Gross Margin | 37.23% |
| Net Profit Margin | 26.95% |
| Debt/Equity Ratio | 0% |
How did 1777 perform over the long term?
See historical performance and comparison